The oversubscription was led by Gabriel Investment Syndicate with backing from several angel groups and regional agencies.
"We are thrilled to be supported by such a strong group of investors with varied and complementary experience. Women’s health rarely gets the investment it needs or deserves; it was refreshing to see the investors understand the gap and opportunity. Oversubscribing on our first round across just 4 weeks of pitching is a testament to the plan we have in place. We are excited to get back to business and scale GLORIAH!"
Winfred reads them overnight, pulls out the facts, checks them against Companies House and files them. It was built by C8VA, who do the same kind of work for other businesses: turning messy, unstructured material into something you can search, count and rely on.
HERmesa led the pre-seed round, which includes backing from multiple institutional investors and Innovate UK grants.
"When only a small minority can deliver best practice, the problem isn’t effort. It’s design. I brought what I was seeing in practice, and I brought the evidence that already existed but simply wasn’t being used consistently. Peripear exists because the standard of care couldn’t possibly be the best we could do,"
FoodLabs and Eka Ventures led the seed round to support product expansion and new clinical trials.
"They’re finally feeling validated. They go to the doctor time and time again and they’re dismissed, being told their symptoms are not connected, what they’re dealing with is normal… they finally feel like a sense of validation, like I was right all along"
